 Reckitt Benckiser Group PLC LSE:RKT, ETR:3RB quarterly results on Friday may have a few pick-me-ups for investors, with numbers from the Strepsils and Nurofen maker also given context from rivals Unilever and GlaxoSmithKline earlier in the week. Top shelf of the bathroom cabinet in the news is likely to be potential news on RBs infant nutrition business, where reports emerged this week that a sale process has been kicked off. 